ISPOR Europe
Vienna, Austria, Nov 8-11, 2026
Find CDA at Booth #723
- Monday, Nov 9: 9:30-19:00
- Tuesday, Nov 10: 9:30-19:00
- Wednesday, Nov 11: 8:30-11:30
Poster Presentations
Monday
Session 1 Discussion: 12:30-13:30
- CO28: Projected impact of personalized mRNA neoantigen vaccines on melanoma recurrence in Medicare beneficiaries: A parametric survival and threshold cost-effectiveness analysis
Session 2 Discussion: 18:00-19:00
- EE213: Treatment patterns, healthcare resource utilization and costs among patients with tenosynovial giant cell tumor (TGCT) in the United States
- CO73: The hidden cost of waiting: Earlier CAR T access reduces 5-year total spending in relapsed/refractory diffuse large B cell lymphoma
- RWD58: Real-world utilization of talazoparib plus enzalutamide in metastatic castration-resistant prostate cancer in the United States
Tuesday
Session 3
Poster Tour Presentation: 11:45-12:30
- PT26: Glucagon-like peptide-1-based anti-obesity medications reduce incident Obstructive Sleep Apnea in Older Adults: Real-World Evidence TOP 5%
Learn more about ISPOR Europe.
Find more CDA presentations and publications here.
